Tabula Rasa HealthCare Inc. (NASDAQ:TRHC) saw an upside of 31.80% to $10.32 after adding $2.49 on Monday. The 5-day average trading volume is 325,488 shares of the company’s common stock. It has gained $10.37 in the past week and touched a new high 3 times within the past 5 days. An average of 155,007 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 178,697.
TRHC’s 1-month performance is 32.14% or $2.50 on its low of $7.50 reached on 08/03/23. The company’s shares have touched a 52-week low of $3.15 and high of $9.12, with the stock’s rally to the 52-week high happening on 08/07/23. YTD, TRHC has achieved 108.48% or $5.36 and has reached a new high 16 times. However, the current price is up 13.16% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
TRHC stock investors last saw insider trading activity on Dec 12.Purcell Michael J. (Director) most recently sold 10,000 shares at $4.26 per share on Dec 09. This transaction cost the insider $42,600.
Valuation Metrics
TRHC stock has a beta of 1.64. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.87.
Tabula Rasa HealthCare Inc.’s quick ratio for the period ended March 30 was 1.60, with the current ratio over the same period at 1.70. In terms of profitability, the gross margin trailing 12 months is 22.90%. The trailing 12-month EBITDA margin is -9.33% while for the period ending March 30, Tabula Rasa HealthCare Inc.’s operating margin was -17.80%. The firm’s gross profit as reported stood at $66.91 million against revenue of $299.52 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -77.3% to -$15.9 million, while revenue of -$29.64 million was -86.42% off the previous quarter. Analysts expected TRHC to announce -$0.14 per share in earnings in its latest quarter, but it posted -$0.02, representing a 85.70% surprise. EBITDA for the quarter stood at more than $0.38 million. TRHC stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 426.46 million, with total debt at $341.52 million. Shareholders hold equity totaling $26.85 million.
Let’s look briefly at Tabula Rasa HealthCare Inc. (TRHC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 04 August was 78.21% to suggest the stock is trending Overbought, with historical volatility in this time period at 145.87%.
The stock’s 5-day moving average is $8.31, reflecting a +28.39% or $2.28 change from its current price. TRHC is currently trading +23.62% above its 20-day SMA, +77.76% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +90.93% and SMA200 by+134.85%.
Stochastic %K and %D was 47.37% and 27.16% and the average true range (ATR) pointed at 0.72. The RSI (14) points at 72.73%, while the 14-day stochastic is at 97.91% with the period’s ATR at 0.65. The stock’s 9-day MACD Oscillator is pointing at 0.54 and 0.42 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Tabula Rasa HealthCare Inc. (NASDAQ: TRHC), SVB Securities upgraded it to an Outperform rating. They previously had a Market perform rating on the stock. Analysts offering their rating for TRHC stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate TRHC as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is TRHC’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $6.00 and a high of $11.00, with their median price target at $8.25. Looking at these predictions, the average price target given by analysts is for Tabula Rasa HealthCare Inc. (TRHC) stock is $8.38.
